Terms: = Germ cell tumor AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
24 results:
1. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
2. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S; Jackson MR; Williams K; Stobo J; Kelly C; Sweeting L; Shad S; Herbert C; Short SC; Williamson A; James A; Nowicki S; Bulbeck H; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1371-1378. PubMed ID: 38211641
[TBL] [Abstract] [Full Text] [Related]
3. Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
Sharma A; Garg A; Singh M; Sharma MC; Gupta S; Kunhiparambath H; Tripathi M; Kale SS; Bal C
Nucl Med Commun; 2024 Feb; 45(2):139-147. PubMed ID: 38095139
[TBL] [Abstract] [Full Text] [Related]
4. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
Cunha C; Marinheiro D; Ferreira BJML; Oliveira H; Daniel-da-Silva AL
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375331
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Neural Progenitor cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract] [Full Text] [Related]
6. Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Tew A; Khoja L; Pallan L; Steven N
J Oncol Pharm Pract; 2023 Jul; 29(5):1163-1171. PubMed ID: 35607278
[TBL] [Abstract] [Full Text] [Related]
7. The National Cancer Database: Survival Between Head and Neck Melanoma and Melanoma of Other Regions.
Cabrera CI; Li S; Conic R; Gastman BR
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):286-297. PubMed ID: 34699278
[TBL] [Abstract] [Full Text] [Related]
8. Dissecting tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
Front Immunol; 2021; 12():709986. PubMed ID: 34512630
[TBL] [Abstract] [Full Text] [Related]
9. Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy.
Zhang D; Zhang W; Wu X; Li Q; Mu Z; Sun F; Zhang M; Liu G; Hu L
Int J Nanomedicine; 2021; 16():3457-3472. PubMed ID: 34045853
[TBL] [Abstract] [Full Text] [Related]
10. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract] [Full Text] [Related]
11. Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
Tao J; Fei W; Tang H; Li C; Mu C; Zheng H; Li F; Zhu Z
Mol Pharm; 2019 Feb; 16(2):786-797. PubMed ID: 30620881
[TBL] [Abstract] [Full Text] [Related]
12. EpCAM antibody-conjugated mesoporous silica nanoparticles to enhance the anticancer efficacy of carboplatin in retinoblastoma.
Qu W; Meng B; Yu Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():646-651. PubMed ID: 28482574
[TBL] [Abstract] [Full Text] [Related]
13. An msn-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.
Shi J; Hou S; Huang J; Wang S; Huan W; Huang C; Liu X; Jiang R; Qian W; Lu J; Wang X; Shi W; Huang R; Chen J
Nanoscale; 2017 Jul; 9(26):8970-8981. PubMed ID: 28443896
[TBL] [Abstract] [Full Text] [Related]
14. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation.
Rizzi M; Tonello S; Estevão BM; Gianotti E; Marchese L; Renò F
J Photochem Photobiol B; 2017 Feb; 167():1-6. PubMed ID: 28039784
[TBL] [Abstract] [Full Text] [Related]
15. A phase II single institution single arm prospective study with paclitaxel, ifosfamide and cisplatin (TIP) as first-line chemotherapy in high-risk germ cell tumor patients with more than ten years follow-up and retrospective correlation with ERCC1, Topoisomerase 1, 2A, p53 and HER-2 expression.
Ligia Cebotaru C; Zenovia Antone N; Diana Olteanu E; Bejinariu N; Buiga R; Todor N; Ioana Iancu D; Eliade Ciuleanu T; Nagy V
J BUON; 2016; 21(3):698-708. PubMed ID: 27569093
[TBL] [Abstract] [Full Text] [Related]
16. Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells.
Vazquez-Mellado MJ; Aguilar C; Rocha-Zavaleta L
Life Sci; 2015 Sep; 137():142-9. PubMed ID: 26232556
[TBL] [Abstract] [Full Text] [Related]
17. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract] [Full Text] [Related]
18. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract] [Full Text] [Related]
19. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor.
Parashar B; Latha Shankar S; O'Guin K; Butler J; Vikram B; Shafit-Zagardo B
J Neurooncol; 2005 Jan; 71(2):141-8. PubMed ID: 15690129
[TBL] [Abstract] [Full Text] [Related]
[Next]
